Clinical Trials
20 trialsNCT05655546 2025-08-08
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Scripps Translational Science Institute
Phase NA Terminated
NCT05904236 2025-04-08
ICVB-1042
IconOVir Bio
Phase 1 Terminated
NCT03250299 2024-06-24
Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Basilea Pharmaceutica
Phase 1 Terminated
NCT01044745 2023-09-06
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
University of Nebraska
Phase 2 Terminated
NCT01367301 2023-08-21
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
Albert Einstein College of Medicine
Phase NA Terminated
NCT03607682 2020-08-04
Tumor-Treating Fields Therapy in Preventing Brain Tumors in Participants With Extensive-Stage Small Cell Lung Cancer
Vanderbilt-Ingram Cancer Center
Phase NA Terminated
NCT01671488 2020-02-17
276
Brown University
Phase 1/2 Terminated
NCT00415246 2019-11-22
Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer
Ipsen
Phase 3 Terminated
NCT02132884 2019-09-04
Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Fox Chase Cancer Center
Phase NA Terminated
NCT03049358 2019-02-05
Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer
Stanford University
Phase NA Terminated
NCT01892293 2019-01-10
CT Antigen TCR-Engineered T Cells for Myeloma
Adaptimmune
Phase 1/2 Terminated
NCT01357863 2018-09-14
(TYCO1)
GlaxoSmithKline
Terminated
NCT00354172 2017-12-28
Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00244894 2017-04-28
Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
NCT00360828 2017-03-23
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT00909662 2015-10-02
Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Case Comprehensive Cancer Center
Terminated
NCT01851161 2015-09-18
Prone Patient Positioning in Reducing Tumor Motion and Improving Breathing Reproduction in Patients With Lung Cancer Undergoing Radiation Therapy
Virginia Commonwealth University
Terminated
NCT01050439 2015-04-15
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
Columbia University
Phase 2 Terminated
NCT01407341 2014-02-06
Beta-Tricalcium Phosphate Bone Graft in Treating Patients Undergoing Surgery For Metastatic Spine Cancer
University of Southern California
Phase 1 Terminated
NCT00312442 2010-06-02
Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy
STEBA France
Phase 2/3 Terminated